Duzallo is a New Combo Med for Chronic Gout

Duzallo (doo-ZAL-oh) will be a new chronic gout med that combines lesinurad with allopurinol.

Reps will tout Duzallo as a combo that targets both causes of gout. Allopurinol decreases uric acid production...and lesinurad (Zurampic) increases renal uric acid excretion, similar to probenecid.

Duzallo helps about one more in 4 patients reach uric acid goals...compared to about 300 mg/day of allopurinol alone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote